Article Information
History
- April 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- João Viana, MSc1,2,
- Christiaan H. van Dorp, PhD3,
- Ana Nunes, PhD2,4,
- Manuel C. Gomes, PhD2,
- Michiel van Boven, PhD1,
- Mirjam E. Kretzschmar, PhD1,
- Marc Veldhoen, PhD5 and
- Ganna Rozhnova, PhD*,1,4
- 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 2Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal
- 3Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, USA
- 4BioISI—Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal
- 5Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
- ↵*Corresponding author: Dr. Ganna Rozhnova, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500 Utrecht, The Netherlands, Email: g.rozhnova{at}umcutrecht.nl, Phone: +31 631117965
Posted April 04, 2021.
Controlling the pandemic during the SARS-CoV-2 vaccination rollout: a modeling study
